"Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2." Neurology: Clinical Practice
11.5
(2021):
e682-e685.
Web. 22 Mar. 2023.
Advertisement
A peer-reviewed clinical neurology journal for the practicing neurologist
